When early prophase PtK1 or Indian muntjac cells are exposed to topoisomerase II (topo II) inhibitors that induce little if any DNA damage, they are delayed from entering mitosis. We show that this delay is overridden by inhibiting the p38, but not the ATM, kinase. Treating early prophase cells with hyperosmotic medium or a histone deacetylase inhibitor similarly delays entry into mitosis, and this delay can also be prevented by inhibiting p38. Together, these results reveal that agents or stresses that induce global changes in chromatin topology during G2 delay entry into mitosis, independent of the ATM-mediated DNA damage checkpoint, by activating the p38 MAPK checkpoint. The presence of this pathway obviates the necessity of postulating the existence of multiple “chromatin modification” checkpoints during G2. Lastly, cells that enter mitosis in the presence of topo II inhibitors form metaphase spindles that are delayed in entering anaphase via the spindle assembly, and not the p38, checkpoint.
Skip Nav Destination
Article navigation
16 August 2004
Article|
August 09 2004
Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway
Alexei Mikhailov,
Alexei Mikhailov
1Division of Molecular Medicine, Wadsworth Center, New York State Department of Health, Empire State Plaza, Albany, NY 12201
Search for other works by this author on:
Mio Shinohara,
Mio Shinohara
1Division of Molecular Medicine, Wadsworth Center, New York State Department of Health, Empire State Plaza, Albany, NY 12201
2Department of Biomedical Sciences, State University of New York, Albany, NY 12222
Search for other works by this author on:
Conly L. Rieder
Conly L. Rieder
1Division of Molecular Medicine, Wadsworth Center, New York State Department of Health, Empire State Plaza, Albany, NY 12201
2Department of Biomedical Sciences, State University of New York, Albany, NY 12222
3Marine Biology Laboratory, Woods Hole, MA 02543
Search for other works by this author on:
Alexei Mikhailov
1Division of Molecular Medicine, Wadsworth Center, New York State Department of Health, Empire State Plaza, Albany, NY 12201
Mio Shinohara
1Division of Molecular Medicine, Wadsworth Center, New York State Department of Health, Empire State Plaza, Albany, NY 12201
2Department of Biomedical Sciences, State University of New York, Albany, NY 12222
Conly L. Rieder
1Division of Molecular Medicine, Wadsworth Center, New York State Department of Health, Empire State Plaza, Albany, NY 12201
2Department of Biomedical Sciences, State University of New York, Albany, NY 12222
3Marine Biology Laboratory, Woods Hole, MA 02543
Address correspondence to Conly L. Rieder, Lab of Cell Regulation, Division of Molecular Medicine, Wadsworth Center, P.O. Box 509, Albany, NY 12201-0509. Tel.: (518) 474-6774. Fax: (518) 486-4801. email: [email protected]
Abbreviations used in this paper: DSB, double-strand break; IMF, immunofluorescence; JNK, Jun-N-terminal; NEB, nuclear envelope breakdown; topo II, topoisomerase II.
Received:
May 27 2004
Accepted:
July 09 2004
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2004
J Cell Biol (2004) 166 (4): 517–526.
Article history
Received:
May 27 2004
Accepted:
July 09 2004
Citation
Alexei Mikhailov, Mio Shinohara, Conly L. Rieder; Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway . J Cell Biol 16 August 2004; 166 (4): 517–526. doi: https://doi.org/10.1083/jcb.200405167
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement